Shoulder Innovations (SI) said late Wednesday that it will collaborate with ALM Ortho to introduce a
Shoulder Innovations (SI) said Tuesday it has entered into an agreement with Catalyst OrthoScience t
Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. Mr. Osborne, who most recently served as Vice President of Commercial Development, will now have responsibility for all elements of Shoulder Innovations' commercial organization and will work closely with
Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will present at the Canaccord Genuity 46th Annual Growth Conference. The presentation will take place at 1:30 p.m. ET / 10:30 a.m. PT on Wednesday, August 12, 2026.
Advita Ortho, a global medical technology leader, announced today it has obtained three novel intellectual property applications from Bauer Innovations that expand Advita's growing Equinoxe® Shoulder System portfolio, extending its capabilities to treat patients with glenoid bone loss using reverse total shoulder arthroplasty (rTSA).
This is the newest page. Registered accounts read further back.